Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Conditions
Parkinson Disease · Essential Tremor · Dystonia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890University of Miami Hospital, Miami, Florida, United States
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890University of South Florida, Tampa, Florida, United States
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890St. Luke's Regional Medical Center, Boise, Idaho, United States
Contact: Study coordinator (Boston Scientific Clinical Research) · BSNClinicalTrials@bsci.com · 855-213-9890Albany Medical Center, Albany, New York, United States
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890Swedish Neuroscience Institute, Seattle, Washington, United States
AZ St. Lucas, Ghent, Belgium
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890AZ Delta, Roeselare, Belgium
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890Hopital Fondation Adolphe de Rothschild, Paris, France
Contact: Study coordinator (Boston Scientific Clinical Research) · BSNClinicalTrials@bsci.com · 855-213-9890Uniklinik Köln, Cologne, Germany
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890Universitaetsklinikum Dusseldorf, Düsseldorf, Germany
Contact: Study coordinator (Boston Scientific Clinical Research) · BSNClinicalTrials@bsci.com · 855-213-9894Uniklinikum Jena, Jena, Germany
Universitaetsklinikum Schleswig-Holstein, Lübeck, Germany
Contact: Study coordinator (Boston Scientific Clinical Research) · BSNClinicalTrials@bsci.com · 855-213-9890Universitaetsklinikum Wuerzburg, Würzburg, Germany
Contact: Study coordinator (Boston Scientific Clinical Research Manager) · BSNClinicalTrials@bsci.com · 855-213-9890Fondazione Istituto Neurologico Casimiro Mondino, Pavia, Italy
Contact: Study coordinator (Boston Scientific Clinical Research) · BSNClinicalTrials@bsci.com · 855-213-9890Hospital Virgen Del Rocio, Seville, Spain
Contact: Study coordinator (Boston Scientific Clinical Research) · BSNClinicalTrials@bsci.com · 855-213-9890
Study leads
Natalie Bloom Lyons
Study Director
Boston Scientific Neuromodulation Corporation